Gene · 1308
Papers3,031
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 3,031
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Association of immune checkpoint inhibitor-induced bullous pemphigoid with underlying cancer type: A lack of association with cancer tissue COL17A1 mutations and dysregulation. | JID Innov | 2026 | 41658267 | PubTator, text mining | PubMed |
| Obesity- and tumor-derived signals drive cancer-associated state transitions in breast mesenchymal stromal/stem cells reprogrammed by IL1RA or JAK inhibition. | Exp Hematol Oncol | 2026 | 41645323 | PubTator, text mining | PubMed |
| A Widespread Pruritic Blistering Eruption in a Young Female. | Int J Dermatol | 2026 | 41612501 | PubTator, text mining | PubMed |
| Diagnostic value of direct immunofluorescence in oral mucous membrane pemphigoid: a retrospective study. | An Bras Dermatol | 2026 | 41604967 | PubTator, text mining | PubMed |
| Targeting cancer stem cells as the most aggressive and tumor-initiating cells. | Transl Oncol | 2026 | 41604836 | PubTator, text mining | PubMed |
| Autoantibodies as predictors for immune-related adverse events in checkpoint inhibition therapy of metastatic melanoma. | J Immunother Cancer | 2026 | 41592893 | PubTator, text mining | PubMed |
| Novel frameshift variant in exon 7 of COL17A1 in a domestic shorthair kitten with junctional epidermolysis bullosa. | J Vet Diagn Invest | 2026 | 41588668 | PubTator, text mining | PubMed |
| Transcriptomic profiling and machine learning uncover gene signatures of psoriasis endotypes and disease severity. | Commun Med (Lond) | 2026 | 41565778 | PubTator, text mining | PubMed |
| Cataract surgery with autosomal recessive cornea plana caused by a novel KERA mutation. | Am J Ophthalmol Case Rep | 2026 | 41550454 | PubTator, text mining | PubMed |
| Mucous Membrane Pemphigoid during CPX-351 Therapy Successfully Treated with Corticosteroids. | Intern Med | 2026 | 41535051 | PubTator, text mining | PubMed |
| Laminin N-terminus α31 regulates corneal epithelial cell adhesion and migration through modifying the organization and proteolytic processing of laminin 332. | PLoS One | 2026 | 41528979 | PubTator, text mining | PubMed |
| Comparison of two ELISA assays for the detection of anti-BP180 autoantibodies. | Scand J Clin Lab Invest | 2026 | 41518073 | PubTator, text mining | PubMed |
| High-throughput proteomics uncovers molecular clusters and biomarkers of severity in bullous pemphigoid. | J Eur Acad Dermatol Venereol | 2026 | 41392513 | PubTator, text mining | PubMed |
| Genetic analysis of a Chinese family with non-syndromic tooth agenesis may reveal a potential multi-locus etiology. | Gene | 2026 | 41274390 | PubTator, text mining | PubMed |
| Revisiting the Pathology of Bullous Pemphigoid: Basal Cell Necrosis as a Diagnostic Clue and Its Pathogenic Role. | J Dermatol | 2026 | 41246878 | PubTator, text mining | PubMed |
| Sensitivity and Specificity of ELISA Tests Detecting BP180 and BP230 Antibodies in the Diagnosis of Bullous Pemphigoid: A Systematic Review and Meta-Analysis. | Int J Dermatol | 2026 | 41222109 | PubTator, text mining | PubMed |
| A Single-cell and Spatially Resolved Cell Atlas of Human Esophageal Squamous Cell Carcinoma. | Genomics Proteomics Bioinformatics | 2026 | 41191515 | PubTator, text mining | PubMed |
| Adjuvant therapy of severe and/or refractory bullous pemphigoid with immunoadsorption - A prospective monocenter pilot study. | J Dtsch Dermatol Ges | 2026 | 41178182 | PubTator, text mining | PubMed |
| Prime editing as a promising therapeutic strategy for junctional epidermolysis bullosa. | Mol Ther | 2026 | 41174881 | PubTator, text mining | PubMed |
| From Diabetes to Dermatology: The Role of Teneligliptin in Bullous Pemphigoid Development. | Curr Diabetes Rev | 2026 | 41102958 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1308/papers?page=5